Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on Self-Efficacy and Mood in Elderly with Mild Cognitive Impairment

Neurorehabilitation and Neural Repair

Volumn 18, Issue 3, 2004, Pages 166-175

  Luijpen, Marijn W ^a   Swaab, Dick F ^b   Sergeant, Joseph A ^a   Scherder, Erik J A ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Mild cognitive impairment (MCI); Mood; Selfefficacy; Transcutaneous electrical nerve stimulation (TENS)

Indexed keywords

AFFECT; AGED; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; HOME FOR THE AGED; HUMAN; MALE; MORALITY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; ALZHEIMER DISEASE; CLINICAL ARTICLE; DEMENTIA; GENERAL SELF EFFICACY SCALE; GERIATRIC DEPRESSION SCALE; GRONINGER ACTIVITY RESTRICTION SCALE; MEMORY; MOOD; PSYCHOMETRY; RESIDENTIAL HOME; SCORING SYSTEM; VERBAL BEHAVIOR;

ACTIVITIES OF DAILY LIVING; AFFECT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEPRESSION; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; MORALE; SELF EFFICACY; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME;

EID: 7444247488     PISSN: 08884390     EISSN: None     Source Type: Journal    
DOI: 10.1177/0888439004268785     Document Type: Article

References (78)

1. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56(9):1133-1142.
2. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58(12):1985-1992.
3. Meyer J, Xu G, Thornby J, Chowdhury M, Quach M. Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J Neurol Sci 2002; 201(1-2):19-25.
4. Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev 2000; 24(3):365-374.
5. Wang QS, Zhou JN. Retrieval and encoding of episodic memory in normal aging and patients with mild cognitive impairment. Brain Res 2002; 924(1):113-115.
6. Wolf H, Grunwald M, Ecke GM, et al. The prognosis of mild cognitive impairment in the elderly. J Neural Transm Suppl 1998; 54: 31-50.
7. Raz N, Gunning FM, Head D, et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex 1997; 7(3):268-282.
8. Bartres-Faz D, Junque C, Lopez-Alomar A, et al. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities. J Am Geriatr Soc 2001; 49(7):985-990.
9. Huang C, Wahlund LO, Almkvist O, et al. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage 2003; 19(3):1137-1144.
10. Morris JC. Challenging assumptions about Alzheimer's disease: mild cognitive impairment and the cholinergic hypothesis. Ann Neurol 2002; 51(2):143-144.
11. Grimes AL, McCullough LB, Kunik ME, Molinari V, Workman RH Jr. Informed consent and neuroanatomic correlates of intentionality and voluntariness among psychiatric patients. Psychiatr Serv 2000; 51(12):1561-1567.
12. Cahn-Weiner DA, Boyle PA, Malloy PF. Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol 2002; 9(3):187-191.
13. Grigsby J, Kaye K, Baxter J, Shetterly SM, Hamman RF. Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J Am Geriatr Soc 1998; 46(5):590-596.
14. Richardson J, Bedard M, Weaver B. Changes in physical functioning in institutionalized older adults. Disabil Rehabil 2001; 23(15):683-689.
15. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977; 84(2):191-215.
16. Barkley RA. The executive functions and self-regulation: an evolutionary neuropsychological perspective. Neuropsychol Rev 2001; 11(1):1-29.
17. Davis KD, Taylor SJ, Crawley AP, Wood ML, Mikulis DJ. Functional MRI of pain- and attention-related activations in the human cingulate cortex. J Neurophysiol 1997; 77(6): 3370-3380.
18. Scherder EJ, Bouma A, Steen AM. Effects of short-term transcutaneous electrical nerve stimulation on memory and affective behaviour in patients with probable Alzheimer's disease. Behav Brain Res 1995; 67(2):211-219.
19. Scherder EJ, Bouma A, Steen LM. Effects of “isolated” transcutaneous electrical nerve stimulation on memory and affective behavior in patients with probable Alzheimer's disease. Biol Psychiatry 1998; 43(6):417-424.
20. Scherder EJ, Bouma A. Effects of transcutaneous electrical nerve stimulation on memory and behavior in Alzheimer's disease may be stage-dependent. Biol Psychiatry 1999; 45(6):743-749.
21. Scherder EJ, Van Someren EJ, Bouma A, Berg M. Effects of transcutaneous electrical nerve stimulation (TENS) on cognition and behaviour in aging. Behav Brain Res 2000; 111(1-2):223-225.
22. Mancuso CA, Rincon M, McCulloch CE, Charlson ME. Self-efficacy, depressive symptoms, and patients' expectations predict outcomes in asthma. Med Care 2001; 39(12):1326-1338.
23. Swaab DF, Dubelaar EJ, Hofman MA, Scherder EJ, Van Someren EJ, Verwer RW. Brain aging and Alzheimer's disease; use it or lose it. Prog Brain Res 2002; 138: 343-373.
24. Swaab DF. Nuclei of the human hypothalamus. Part 1. In: Aminos MJ, Boller S, Swaab DF, eds. Handbook of clinical neurology. Amsterdam: Elsevier Science; 2003.
25. Swaab DF. Neuropathology of the human hypothalamus and adjacent structures. Part 2. In: Aminos MJ, Boller S, Swaab DF, eds. Handbook of clinical neurology. Amsterdam: Elsevier Science; 2004.
26. Kayama Y, Koyama Y. Brainstem neural mechanisms of sleep and wakefulness. Eur Urol 1998; 33(Suppl 3):12-15.
27. Van Gaalen M, Kawahara H, Kawahara Y, Westerink BH. The locus coeruleus noradrenergic system in the rat brain studied by dual-probe microdialysis. Brain Res 1997; 763(1):56-62.
28. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3):189-198.
29. Dufouil C, Clayton D, Brayne C, et al. Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology 2000; 55(11):1609-1613.
30. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56(3):303-308.
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34(7):939-944.
32. Wechsler D. Wechsler Memory Scale-Revised. New York: The Psychological Corporation; 1984.
33. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. Research edition. New York: The Psychological Corporation Harcourt Brace Jovanovich Inc; 1987.
34. Mulder JL, Dekker R, Dekker PH. Verbale Leer en Geheugen Test. Lisse, the Netherlands: Swets & Zietlinger; 1995.
35. Snijders J Th, Verhage F. Groninger Intelligentie Test. Lisse, the Netherlands: Swets & Zeitlinger; 1983.
36. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychology Test Battery. Tuscon, AZ: Neuropsychology Press; 1985.
37. Bosscher RJ, Smith JH, Kempen GIJM. Algemene competentieverwachtingen bij ouderen. Nederlands Tijdschrift voor de Psychologie 1997; 52: 239-248.
38. Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Rogers RW. The self-efficacy scale: construction and validation. Psychol Rep 1982; 51: 663-671.
39. Bosscher RJ, Baardman I. Het meten van gepercipeerde competentie bij psychiatrische patienten. Bewegen en Hulpverlening 1989; 6: 312-322.
40. Bosscher RJ, Laurijssen L, Boer Ed. Competentie op latere leeftijd: een exploratieve studie. Bewegen en Hulpverlening 1992; 9: 255-265.
41. Suurmeijer TP, Doeglas DM, Moum T, et al. The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health 1994; 84(8): 1270-1273.
42. Kempen GIJM, Suurmeijer ThPBM. The development of a hierarchical polychotomous ADL-IADL scale for noninstitutionalized elders. The Gerontologist 1990; 30: 497-502.
43. Kempen GIJM, Doeglas DM, Suurmeijer TPBM. Het meten van problemen met zelfredzaamheid op verzorgend en huishoudelijk gebied met de Groningen Activiteiten Restrictie Schaal (GARS). Een handleiding [Grongingen Activity Restriction Scale]. Groningen, the Netherlands: University of Groningen, Northern Centre for Health Care Research; 1993.
44. Lawton MP. The Philadelphia Geriatric Center Morale Scale: a revision. J Gerontol 1975; 30(1):85-89.
45. Lawton MP. The dimensions of morale. In: Kent D, Kastenbaum R, Sherwood S, eds. Research, planning and action for the elderly. New York: Behavioral Publications; 1972.
46. Rai GS, Jetten E, Collas D, Hoefnagels W, Froeling P, Bor H. Study to assess quality of life (morale and happiness) in two continuing care facilities—a comparative study in the UK and the Netherlands. Arch Gerontol Geriatr 1995; 20: 249-253.
47. Brink TL, Yesavage JA, Heersema PH, Adey M, Rose TL. Screening tests for geriatric depression. Arch Gen Psychiatry 1982; 4: 53-63.
48. Sheikh JL, Yesavage JA. Geriatric Depression Scale (GDS). Recent evidence of development of a shorter version. Clin Gerontol 1986; 5: 165-173.
49. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17(1):37-49.
50. Kok RM, Heeren ThJ, van Hemert AM. De Geriatric Depression Scale. Tijdschrift voor Psychiatrie 1993; 35(6):416-421.
51. Laprise R, Vézina J. Diagnostic performance of the Geriatric Depression Scale and the Beck Depression Inventory with nursing home residents. Can J Aging 1998; 17(4):401-413.
52. Dudar JD, Whishaw IQ, Szerb JC. Release of acetylcholine from the hippocampus of freely moving rats during sensory stimulation and running. Neuropharmacology 1979; 18(8-9):673-678.
53. Dutar P, Lamour Y, Jobert A. Activation of identified septohippocampal neurons by noxious peripheral stimulation. Brain Res 1985; 328(1):15-21.
54. Huan-Ji D, Yan-fang C. Localization of central structures involved in descending inhibitory effect of acupuncture on viscero-somatic reflex discharges. Sci Sin 1976; 19: 137-148.
55. Coffey GH, Mahon MV. Pain: theories and a new approach to treatment. J Natl Med Assoc 1982; 74(2):147-153.
56. Howson DC. Peripheral neural excitability. Implications for transcutaneous electrical nerve stimulation. Phys Ther 1978; 58(12):1467-1473.
57. Guieu R, Tardy-Gervet MF, Blin O, Pouget J. Pain relief achieved by transcutaneous electrical nerve stimulation and/or vibratory stimulation in a case of painful legs and moving toes. Pain 1990; 42(1):43-48.
58. Guieu R, Tardy-Gervet MF, Roll JP. Analgesic effects of vibration and transcutaneous electrical nerve stimulation applied separately and simultaneously to patients with chronic pain. Can J Neurol Sci 1991; 18(2):113-119.
59. Omura Y. Basic electrical parameters for safe and effective electro-therapeutics [electro-acupuncture, TES, TENMS (or TEMS), TENS and electro-magnetic field stimulation with or without drug field] for pain, neuromuscular skeletal problems, and circulatory disturbances. Acupunct Electrother Res 1987; 12(3-4):201-225.
60. Jorum E, Shyu BC. Analgesia by low-frequency nerve stimulation mediated by low-threshold afferents in rats. Pain 1988; 32(3):357-366.
61. Jones SL, Gebhart GF. Spinal pathways mediating tonic, coeruleospinal, and raphe-spinal descending inhibition in the rat. J Neurophysiol 1987; 58(1):138-159.
62. Mokha SS, McMillan JA, Iggo A. Descending control of spinal nociceptive transmission. Actions produced on spinal multi-receptive neurones from the nuclei locus coeruleus (LC) and raphe magnus (NRM). Exp Brain Res 1985; 58(2): 213-226.
63. Soric R, Devlin M. Transcutaneous electrical nerve stimulation. Practical aspects and applications. Postgrad Med 1985; 78(4): 101-107.
64. Wolf SL. Perspectives on central nervous system responsiveness to transcutaneous electrical nerve stimulation. Phys Ther 1978; 58(12):1443-1449.
65. Duranti R, Pantaleo T, Bellini F. Increase in muscular pain threshold following low frequency-high intensity peripheral conditioning stimulation in humans. Brain Res 1988; 452(1-2):66-72.
66. Eriksson MB, Sjolund BH, Nielzen S. Long term results of peripheral conditioning stimulation as an analgesic measure in chronic pain. Pain 1979; 6(3):335-347.
67. Scherder EJ, Luijpen MW, van Dijk KR. Activation of the dorsal raphe nucleus and locus coeruleus by transcutaneous electrical nerve stimulation in Alzheimer's disease: a reconsideration of stimulation-parameters derived from animal studies. Chin J Physiol 2003; 46(4):143-150.
68. Norusis MJ. Statistical Packages for the Social Sciences, SPSS/PC+. New York: McGraw-Hill; 1988.
69. Lopez OL, Jagust WJ, Dulberg C, et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol 2003; 60(10):1394-1399.
70. Van Dyck CH. Neuroimaging in Alzheimer's disease: relevance for treatment. Curr Psychiatry Rep 2001; 3(1):13-19.
71. Sjogren M, Hesse C, Basun H, et al. Tacrine and rate of progression in Alzheimer's disease—relation to ApoE allele genotype. J Neural Transm 2001; 108(4):451-458.
72. Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogenuse, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 2000; 54(10):1949-1954.
73. Benedetti F, Amanzio M, Casadio C, Oliaro A, Maggi G. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 1997; 71(2):135-140.
74. Kennedy WP. The nocebo reaction. Med Exp Int J Exp Med 1961; 95: 203-205.
75. Hahn RA. A sociocultural model of illness and healing. In: White L, Tursky B, Schwartz GE, eds. Placebo: theory, research, and mechanisms. New York: Guilford; 1985: 167-195.
76. Hahn RA. The nocebo phenomenon: scope and foundations. In: Harrington A, ed. The placebo effect: an interdisciplinary exploration. Cambridge, MA: Harvard University Press; 1997.
77. Ader R. Conditioned responses in pharmacotherapy research. Psychol Med 1993; 23(2):297-299.
78. Kirsch I. Specifying nonspecifics: psychological mechanisms of placebo effects. In: Harrington A, ed. The placebo effect. London: Harvard University Press; 1997.